# Glenmark Pharmaceuticals Limited - Inspection Records

Source: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e

> Inspection records and compliance data for Glenmark Pharmaceuticals Limited in Colvale, None. Access full analysis and detailed observations.

---

## Details

- Name: Glenmark Pharmaceuticals Limited
- FEI Number: 3004672766
- City: Colvale
- State: None
- Country Name: India
- Address Line 1: Plot No S - 7, Colvale Industrial Estate
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Glenmark Pharmaceuticals Limited - 2026-06-22](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/e98bef36-5600-4902-bbe5-6b857ceb88c1) — source: FDA, date: June 22, 2026
- [483 - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/057fe8cd-6838-4327-af2d-357c2360ff67) — source: FDA, date: May 20, 2022
- [483 - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/093337ff-63f2-4cf2-8f60-4218782af640) — source: FDA, date: May 20, 2022
- [FDA Inspection 1170118 - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/3db03adb-b93f-4e9a-8ec6-4f05144e5a4f) — classification: Official Action Indicated (OAI), source: FDA, date: May 20, 2022
- [483 - Glenmark Pharmaceuticals Limited - 2019-09-27](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/1b6b5a08-12ee-4621-95d3-64968e415cc1) — source: FDA, date: September 27, 2019
- [483 - Glenmark Pharmaceuticals Limited - 2019-03-15](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/61572250-35a3-4c58-8beb-ef4ed0be77a2) — source: FDA, date: March 15, 2019
- [FDA Inspection 1082656 - Glenmark Pharmaceuticals Limited - 2019-03-15](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/76994ec3-3b82-446f-9cf1-7c06892b1e58) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2019
- [FDA Inspection 885332 - Glenmark Pharmaceuticals Limited - 2014-05-30](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/94186246-e235-4bad-87ed-848e5becfc54) — classification: No Action Indicated (NAI), source: FDA, date: May 30, 2014
- [FDA Inspection 849889 - Glenmark Pharmaceuticals Limited - 2013-07-19](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/d3bf1a09-8a2e-4b48-a074-e7143a83a5d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2013
- [FDA Inspection 752519 - Glenmark Pharmaceuticals Limited - 2011-10-12](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/ffeb2946-9761-4490-b5c7-658b5d38daaa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 12, 2011
- [FDA Inspection 628368 - Glenmark Pharmaceuticals Limited - 2009-11-20](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/9ba33da9-06fd-42b3-b46a-eebadb627bbf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2009

## Related Companies

- [Gland Pharma Limited, Units I+II Pashamylaram Site](https://www.keypedia.com/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca)
- [MassBiologics](https://www.keypedia.com/companies/massbiologics/fa584e7c-22de-470c-836a-dd3028fae600)
- [Patheon Manufacturing Services LLC](https://www.keypedia.com/companies/patheon-manufacturing-services-llc/64087a9c-0f9c-44d7-aeb9-171f7bc13658)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [CoreRX Inc.](https://www.keypedia.com/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)](https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-high-tech-zone-site/94263442-b5c4-4df8-b563-30ae0b9a4206)
- [Jubilant HollisterStier LLC](https://www.keypedia.com/companies/jubilant-hollisterstier-llc/2f8cb6dd-3555-4528-a2d6-d3b845d229ba)
- [NATCO Pharma Limited](https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a)

## Related Officers

- [Sandra A. Hughes](https://www.keypedia.com/people/sandra-a-hughes/ee1b9542-fe28-4618-a666-67a1ff736481)
- [Michele L. Glendenning](https://www.keypedia.com/people/michele-l-glendenning/a3c23a43-634c-4140-807b-c17fbc03bb00)
- [Jose M. Cayuela](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)